Trial of CTX310 for stubborn high cholesterol and fats
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests a new medicine, CTX310, for people with persistently high levels of fats (triglycerides) and cholesterol that have not improved with standard treatments. It aims to see if the drug is safe and tolerable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have high triglycerides (≥150 mg/dL) and high LDL cholesterol (≥70 or 100 mg/dL, depending on your other health conditions) that have not responded to the maximum doses of usual treatments for at least 12 weeks.
- If you are a woman, you must be postmenopausal or surgically sterile (unable to become pregnant).
- Men must use effective contraception during the study and their female partners must also use contraception.
- You do not have a specific genetic condition called familial chylomicronemia syndrome.
- Your liver and kidney function must be within acceptable ranges.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
This study tests a new injectable medication called HST101 for lowering cholesterol in people who are already taking cholesterol pills but still have high levels. It may help if you have heart disease or are at high risk.
This early-stage study tests a new medicine called MWX205 to see if it's safe and how your body processes it. The medicine is designed to help lower high triglycerides and LDL cholesterol (the 'bad' cholesterol), which can increase heart disease risk.
This trial tests an experimental medication called QLC7401 for people with a genetic condition that causes very high cholesterol. It aims to lower cholesterol levels safely and may be an option for those who need better control.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
This early-phase trial tests a new medication called STX-1150 for people with high LDL cholesterol. It aims to see if the drug is safe and how well it works to lower cholesterol.
Hear when a new Cardiovascular trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.